Tranzactioneaza Tricida (US.TCDA) - 0.0925 USD (%) Tranzactioneaza
Indici
Descriere companie
Tricida, Inc. (https://www.tricida.com/) is a pharmaceutical company, which is focused on the development and commercialization of its investigational drug candidate, veverimer (TRC101). TRC101, is a non-absorbed, orally administered polymer designed to treat metabolic acidosis in patients with chronic kidney disease (CKD). Its Veverimer, is a low-swelling, spherical polymer bead that is approximately 100 micrometers in diameter, which is a single, molecular weight, crosslinked polyamine molecule. It is conducting renal outcomes clinical trial, VALOR-CKD (TRCA-303), to determine if veverimer slows CKD progression in patients with metabolic acidosis associated with CKD. Its VALOR-CKD trial is a randomized, double-blind, placebo-controlled, time-to-event trial.